A Web-Based Tailored Nursing Intervention to Increase Walking in Patients After an Acute Coronary Syndrome

January 15, 2018 updated by: Sylvie Cossette, Montreal Heart Institute

Evaluation of a Web-Based Tailored Nursing Intervention (TAVIEenM@RCHE) Aimed at Increasing Walking in Patients After an Acute Coronary Syndrome: A Multicenter Randomized Controlled Trial

Acute coronary syndromes (ACS) are one of the leading causes of coronary artery disease mortality, and among the top reasons for health care utilization in Canada. Physical activity counselling is a core component of secondary prevention interventions because increased physical activity is associated with reduced mortality risk, improved quality of life, reduced coronary risk factors, and reduced health care utilization. Despite these health benefits, between 40% and 60% of patients after an ACS event are insufficiently active. Web-based interventions offer innovative alternatives for intervention delivery via the Internet in secondary prevention. However, there is a paucity of randomized controlled trials testing, in ACS patients, computer-tailored interventions that include videos within the tailored algorithm. The purpose of this multicenter randomized controlled trial is to test a web-based intervention, TAVIEenM@RCHE, that uses tailored-videos of a nurse, the 'virtual nurse', aimed at increasing physical activity through walking in ACS patients.

Study Overview

Detailed Description

After baseline data is collected, the participants (N = 148) will be randomized to either one of two groups: 1) access to the 4-week TAVIEenM@RCHE intervention with an additional "booster" at 8 weeks (experimental group) or 2) access to a list of publicly available websites (control group). Participants will be included if they report insufficient levels of physical activity prior hospitalization, and they have no serious medical conditions impeding adherence to moderate-intensity physical activity. Data collection will occur at recruitment (in-hospital), at baseline (home 3 weeks post-hospital discharge), and at 5 and 12 weeks post baseline. The data analysis will be consistent with intention-to-treat principles. Baseline characteristics will be compared using descriptive statistics to identify trends in group imbalances. For the analysis of the primary outcome of change in steps per day between baseline and 12 weeks, and the secondary outcome of change in steps per day between baseline and 5 weeks, a repeated measures ANCOVA model will compare the adjusted differences between the experimental and control groups at a significance of 0.05. For the analysis of the two secondary outcomes of change in energy expenditure in walking and in moderate-intensity physical activity between baseline and 5 weeks, and between baseline and 12 weeks, a repeated measures MANCOVA model will compare the adjusted differences between the experimental and control groups at a significance of 0.05.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H1P 2G7
        • Montreal Heart Insitute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Discharged 3 weeks home post ACS-related hospitalization.
  2. No serious medical condition exists that would impede adhering to moderate-intensity physical activity. Medical conditions include, for instance, incapacitating chronic pain, paralysis, equilibrium problems, diabetic ulcers, fluid restrictions, dyspnea, home oxygen dependency, cancer and others. Also, no environmental restrictions that would impede walking.
  3. Receives usual care follow-up post ACS-related hospitalization.
  4. Reported access to any computer device that has a USB port and this computer is connected to the Internet to allow upload of data from the accelerometer, and has speaker or headphones to enable listening to the intervention on the computer device of choice.
  5. Reported ability to read and speak French.

Exclusion Criteria:

  1. Reported sufficient physical activity during 6 months prior to hospitalization: performed at least 150 minutes of moderate-intensity physical activity per week (30 minutes five days a week) or at least 75 minutes per week of vigorous-intensity physical activity (25 minutes three days a week).
  2. Indicated in the medical chart or reported by staff, physical or psychological/cognitive that would make it impossible for the patient to provide informed consent.
  3. Documented New York Heart Association Class III to IV heart failure.
  4. Involved in other intensive regular clinical follow-up during TAVIEenM@RCHE.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TAVIEenM@RCHE intervention
The experimental group will receive a web-based tailored nursing intervention. Between 3 and 4 sessions of 15 to 25 minutes each are completed within 4 weeks. A booster session is delivered at 8 weeks post randomization.
The intervention goal is to increase up to 150 minutes per week of moderate-intensity physical activity through walking. The intervention is underpinned by Strengths-Based Nursing Care that specifies nursing values, and by Self-Determination Theory that specifies variables to tailor the intervention. The four intervention strategies are: 1) Providing information and feedback, 2) Exploring reasons to build motivation, 3) Exploring strengths to build confidence (self-efficacy), and 4) Developing an action plan to maintain motivation and confidence (self-efficacy). The TAVIE system platform is designed to provide a fully automated, easy to navigate website, and the main mode of delivery is video clips of a 'virtual nurse' who presents the tailored intervention content.
Active Comparator: Publicly available websites
The control group will receive hyperlinks to four publicly available websites and one online booklet on the topic of walking.
  • Le Programme de marche (Institut de Cardiologie de Montréal)
  • L'activité physique (Institut de Cardiologie de Montréal)
  • L'activité physique (Fondation des maladies du cœur et de l'AVC)
  • Directives canadiennes en matiére d'activité physique à l'intention des adultes âgés de 65 ans et plus (Société Canadienne de Physiologie de l'exercice)
  • Directives canadiennes en matière d'activité physique à l'intention des personnes âgées de 65 et plus (ParticipACTION)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in accelerometer measured steps per day
Time Frame: Baseline, and 12 weeks
Baseline, and 12 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in accelerometer measured steps per day
Time Frame: Baseline, and 5 weeks
Baseline, and 5 weeks
Change in self-reported energy expenditure in walking
Time Frame: Baseline, 5 weeks, and 12 weeks
Baseline, 5 weeks, and 12 weeks
Change in self-reported energy expenditure in moderate to vigorous physical activity
Time Frame: Baseline, 5 weeks, and 12 weeks
Baseline, 5 weeks, and 12 weeks

Other Outcome Measures

Outcome Measure
Time Frame
Self-reported perceived autonomy support
Time Frame: 5 weeks
5 weeks
Change in self-reported controlled motivation
Time Frame: Baseline, and 5 weeks
Baseline, and 5 weeks
Change in self-reported autonomous motivation
Time Frame: Baseline, and 5 weeks
Baseline, and 5 weeks
Change in self-reported perceived competence
Time Frame: Baseline, and 5 weeks
Baseline, and 5 weeks
Change in self-reported barrier self-efficacy
Time Frame: Baseline, and 5 weeks
Baseline, and 5 weeks
Self-reported global quality of life
Time Frame: 12 weeks
12 weeks
Self-reported emotional quality of life
Time Frame: 12 weeks
12 weeks
Self-reported physical quality of life
Time Frame: 12 weeks
12 weeks
Self-reported social quality of life
Time Frame: 12 weeks
12 weeks
Self-reported smoking abstinence
Time Frame: 12 weeks
12 weeks
Self-reported optimal medication use
Time Frame: 12 weeks
12 weeks
Self-reported uptake in a secondary prevention program
Time Frame: 12 weeks
12 weeks
Emergency department visits identified by medical chart review
Time Frame: 12 weeks
12 weeks
Hospitalizations identified by medical chart review
Time Frame: 12 weeks
12 weeks
Self-reported angina frequency
Time Frame: 12 weeks
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sylvie Cossette, Ph.D., Montreal Heart Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2016

Primary Completion (Actual)

October 29, 2017

Study Completion (Actual)

October 29, 2017

Study Registration Dates

First Submitted

November 23, 2015

First Submitted That Met QC Criteria

November 25, 2015

First Posted (Estimate)

December 1, 2015

Study Record Updates

Last Update Posted (Actual)

January 17, 2018

Last Update Submitted That Met QC Criteria

January 15, 2018

Last Verified

January 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Coronary Syndrome

Subscribe